Emergence and high prevalence of unusual rotavirus G8P[8] strains in outpatients with acute gastroenteritis in Shanghai, China.

G8P[8] Group A rotavirus acute gastroenteritis children genotype

Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
Jan 2024
Historique:
revised: 18 12 2023
received: 04 07 2023
accepted: 20 12 2023
medline: 5 1 2024
pubmed: 5 1 2024
entrez: 5 1 2024
Statut: ppublish

Résumé

Group A rotavirus (RVA) is considered an important cause of acute gastroenteritis (AGE) in all age groups, especially in children. We investigated the epidemiology of RVA in outpatients aged ≤ 16 years at the Children's Hospital of Fudan University, Shanghai, China. In this study, 16.6% (246/1482) were infected with RVA. The detection rate of RVA was significantly higher in the year of 2021 (20.3%, 147/725) compared to the year of 2020 (14.5%, 77/531) and 2022 (9.7%, 22/226) (p = 0.000). RVA infection was prevalent in all seasons from 2020 to 2022, with a different monthly distribution observed in different years. Among 246 RVA-positive samples, 14 different RVA genotypes were detected with different frequencies. Overall, G9P[8] (45.5%, 112/246) was the most common RVA genotype, followed by G8P[8] (37.4%, 92/246) and G3P[8] (4.1%, 10/246). The prevalence of G/P combinations varied from 2020 to 2022. G9P[8] was the most prevalent circulating genotype in 2020 (68.2%, 15/22) and 2021 (57.8%, 85/147). However, G8P[8] (68.8%, 53/77) suddenly became the most prevalent genotype in 2022 after being first identified in 2020 and prevalent in 2021. The G8 strains detected in the study were all clustered to DS-1-like G8 strains with the closest genetic distance to strains circulating in Southeast Asia. Our study demonstrated the diversity of circulating RVA genotypes in Shanghai. The sudden emergence and high prevalence of unusual G8P[8] strains deserve more concern and indicate the need for continuous surveillance of RVA in children with AGE in the future to refine future vaccine strategy.

Identifiants

pubmed: 38180381
doi: 10.1002/jmv.29368
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e29368

Subventions

Organisme : The Key Development Program of the Children's Hospital of Fudan University
ID : EK2022ZX05

Informations de copyright

© 2024 Wiley Periodicals LLC.

Références

Troeger C, Blacker BF, Khalil IA, et al. Collaborators GBDDD. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. 2018;18(11):1211-1228.
Lau YL, Fan Leung T, Sirvan Cetin B, et al. Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study. Vaccine. 2022;40(14):2184-2190.
Du Y, Chen C, Zhang X, et al. Global burden and trends of rotavirus infection-associated deaths from 1990 to 2019: an observational trend study. Virol J. 2022;19(1):166.
Estes MK, Greenberg HB. Rotaviruses. In: Knipe DM, Howley PM, eds. Field's Virology. Vol 2. Lippincott Williams & Wilkins; 2013:1347-1401.
Matthijnssens J, Otto PH, Ciarlet M, Desselberger U, Van Ranst M, Johne R. VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation. Arch Virol. 2012;157(6):1177-1182.
Johne R, Tausch SH, Grützke J, et al. Distantly related rotaviruses in common shrews, Germany, 2004-2014. Emerging Infect Dis. 2019;25(12):2310-2314.
Luo S, Chen X, Yan G, et al. Emergence of human-porcine reassortment G9P[19] porcine rotavirus A strain in guangdong province, China. Front Vet Sci. 2023;9:1111919.
Lucien MAB, Esona MD, Pierre M, et al. Diversity of rotavirus strains circulating in Haiti before and after introduction of monovalent vaccine. IJID Regions. 2022;4:146-151.
Zhou X, Wang Y, Chen N, et al. Surveillance of human rotaviruses in Wuhan, China (2019-2022): whole-genome analysis of emerging DS-1-like G8P[8] rotavirus. Int J Mol Sci. 2023;24:12189.
Jiao Y, Han T, Qi X, et al. Human rotavirus strains circulating among children in the capital of China (2018-2022)_ predominance of G9P[8] and emergence ofG8P[8]. Heliyon. 2023;9:e18236.
Tapia MD, Armah G, Breiman RF, et al. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa. Vaccine. 2012;30(suppl 1):A79-A85.
Phan TG, Khamrin P, Quang TD, et al. Detection and genetic characterization of group A rotavirus strains circulating among children with acute gastroenteritis in Japan. J Virol. 2007;81(9):4645-4653.
Lu L, Zhong H, Jia R, et al. Prevalence and genotypes distribution of group A rotavirus among outpatient children under 5 years with acute diarrhea in Shanghai, China, 2012-2018. BMC Gastroenterol. 2022;22(1):217.
Wang SJ, Chen LN, Wang SM, et al. Genetic characterization of two G8P[8] rotavirus strains isolated in Guangzhou, China, in 2020/21: evidence of genome reassortment. BMC Infect Dis. 2022;22(1):579.
Taniguchi K, Urasawa T, Urasawa S. Independent segregation of the VP4 and the VP7 genes in bovine rotaviruses as confirmed by VP4 sequence analysis of G8 and G10 bovine rotavirus strains. J Gen Virol. 1993;74(Pt 6):1215-1221.
Mukhopadhya I, Murdoch H, Berry S, et al. Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland. Vaccine. 2017;35(1):156-163.
Sadiq A, Bostan N, Yinda KC, Naseem S, Sattar S. Rotavirus: genetics, pathogenesis and vaccine advances. Rev Med Virol. 2018;28(6):e2003.
Pindyck T, Tate JE, Parashar UD. A decade of experience with rotavirus vaccination in the United States - vaccine uptake, effectiveness, and impact. Expert Rev Vaccines. 2018;17(7):593-606.
Hoque SA, Khandoker N, Thongprachum A, et al. Distribution of rotavirus genotypes in Japan from 2015 to 2018: diversity in genotypes before and after introduction of rotavirus vaccines. Vaccine. 2020;38(23):3980-3986.

Auteurs

Huaqing Zhong (H)

Department of Pediatric Institute, Children's Hospital of Fudan University & National Children Medical Center, Shanghai, China.

Ran Jia (R)

Department of Clinical Laboratory, Children's Hospital of Fudan University & National Children Medical Center, Shanghai, China.

Menghua Xu (M)

Department of Clinical Laboratory, Children's Hospital of Fudan University & National Children Medical Center, Shanghai, China.

Pengcheng Liu (P)

Department of Clinical Laboratory, Children's Hospital of Fudan University & National Children Medical Center, Shanghai, China.

Liyun Su (L)

Department of Clinical Laboratory, Children's Hospital of Fudan University & National Children Medical Center, Shanghai, China.

Lingfeng Cao (L)

Department of Clinical Laboratory, Children's Hospital of Fudan University & National Children Medical Center, Shanghai, China.

Xunhua Zhu (X)

Department of Clinical Laboratory, Children's Hospital of Fudan University & National Children Medical Center, Shanghai, China.

Lijuan Lu (L)

Department of Clinical Laboratory, Children's Hospital of Fudan University & National Children Medical Center, Shanghai, China.

Jin Xu (J)

Department of Clinical Laboratory, Children's Hospital of Fudan University & National Children Medical Center, Shanghai, China.
Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.

Classifications MeSH